Myelodysplastic Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • Report
  • 1006 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Report
  • 450 Pages
From
Oncology Drug Discovery Services Market, 2017-2030 - Product Thumbnail Image

Oncology Drug Discovery Services Market, 2017-2030

  • Report
  • 270 Pages
From
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 431 Pages
From
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 384 Pages
From
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015 - Product Thumbnail Image

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

  • Report
  • 57 Pages
From
Cancer Metabolism Based Therapeutics, 2017-2030 - Product Thumbnail Image

Cancer Metabolism Based Therapeutics, 2017-2030

  • Report
  • 263 Pages
From
HDAC Inhibitors Market, 2016 - 2026 - Product Thumbnail Image

HDAC Inhibitors Market, 2016 - 2026

  • Report
  • 233 Pages
From
Chondrosarcoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Chondrosarcoma - Pipeline Review, H1 2018

  • Report
  • 280 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017

  • Report
  • 766 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017

  • Report
  • 609 Pages
From
Chondrosarcoma - Pipeline Insight, 2018 - Product Thumbnail Image

Chondrosarcoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Non-Hodgkin Lymphoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H1 2018

  • Report
  • 2186 Pages
From
Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report

  • Report
  • 278 Pages
From
Acute Myeloid Leukaemia:KOL Insight - Product Thumbnail Image

Acute Myeloid Leukaemia:KOL Insight

  • Report
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2017 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2017

  • Report
  • 1829 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2017 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2017

  • Report
  • 1676 Pages
From
Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016 - Product Thumbnail Image

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

  • Report
  • 477 Pages
From
OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026 - Product Thumbnail Image

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026

  • Drug Pipelines
  • 395 Pages
From
Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016 - Product Thumbnail Image

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

  • Report
  • 442 Pages
From
Loading Indicator
adroll